Venkata N S Garikipati
Overview
Explore the profile of Venkata N S Garikipati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kishore R, Garikipati V, Gonzalez C
J Cardiovasc Pharmacol
. 2020 May;
76(2):128-137.
PMID: 32398477
Circular RNAs (circRNAs) have recently been identified as a new class of long noncoding RNAs with gene regulatory roles. These covalently closed transcripts are generated when the pre-mRNA splicing machinery...
2.
Verma S, Garikipati V, Krishnamurthy P, Schumacher S, Grisanti L, Cimini M, et al.
Circulation
. 2017 Jul;
136(10):940-953.
PMID: 28667100
Background: Activated fibroblasts (myofibroblasts) play a critical role in cardiac fibrosis; however, their origin in the diseased heart remains unclear, warranting further investigation. Recent studies suggest the contribution of bone...
3.
4.
Garikipati V, Verma S, Jolardarashi D, Cheng Z, Ibetti J, Cimini M, et al.
Cardiovasc Res
. 2017 Apr;
113(8):938-949.
PMID: 28371849
Aims: Increased miR-375 levels has been implicated in rodent models of myocardial infarction (MI) and with patients with heart failure. However, no prior study had established a therapeutic role of...
5.
Garikipati V, Kishore R
Methods Mol Biol
. 2017 Feb;
1553:85-89.
PMID: 28229409
Bone marrow endothelial progenitor cells (EPCs) have shown a great promise to promote ischemic tissue neovascularization and to attenuate ischemic injury in a variety of animal models, which led to...